To the Editor.—
In the June 17 issue, there is an article on preadmission screening1 and an editorial by Dr Dans1 on the same subject. It is interesting that the main finding of this study was the "failure to detect major adverse outcomes." Furthermore, the authors seem pleased that only 0.37% of requests for admission were denied.It would be nice to see some figures as to the advantages of this expensive and cumbersome screening program. In short, does it do any good? The group from Connecticut implies that as long as no one suffers from the program it is probably all right. There is no mention of the tremendous cost to the Connecticut Peer Review Organization, to physicians, and to the hospital, and this cost is not only financial but a burden of wasted time with telephone calls and paperwork.
George D. Lavers. Preadmission Screening of Medicare Patients. JAMA. 1988;260(19):2833. doi:10.1001/jama.1988.03410190081016